About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

On The Road

Luye Pharma’s Rykindo® (Risperidone Microspheres for Injection (II)) Included in the 2021 Chinese National Reimbursement Drug List ...

News

Luye Pharma Group today announced that Rykindo® (Risperidone Microspheres for Injection (II)), its new anti-schizophrenia drug, has been put on the latest edition of the National Reimbursement Drug List (NRDL) released by China’s ...

December 03,2021

Boan Biotech Publishes Results of Anti-CD25 Antibody Research in Nature Sub-Journal

The findings about BA1106, a fully human monoclonal anti-CD25 antibody developed by Boan Biotech, a subsidiary of Luye Pharma Group, were published in Scientific Reports, which is a journal of the Nature Portfolio. Scientific Reports is the sixth ...

November 25,2021

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company